Beam is a pioneer of the base-editing approach to gene-editing, which can be used to convert one nucleotide base into another without cutting both strands of DNA, unlike other technologies like ...

Beam Therapeutics Inc. (NASDAQ:BEAM) is a biotechnology firm specializing in precision genetic medicines through a technique ...

Beam Therapeutics Inc. (NASDAQ:BEAM) stands at the forefront of genetic medicine development, leveraging its proprietary base editing technology to create precision treatments for serious diseases.